COVID-19 Screening Clinical Pathway — Inpatient | Children's Hospital of Philadelphia

Clinical Pathways Home Emergency ICU Inpatient Outpatient Specialty Care Primary Care

Related Pathways

Inpatient SARS-CoV-2 Testing Recommendations

Testing Recommendations
- Test all symptomatic patients on admission
- Pre-procedure: All symptomatic patients undergoing AGPs in a procedural area, if not tested within 72 hours
- Current inpatients with new infectious symptoms concerning for COVID-19
- Review Caregiver Guidance

Testing and Precaution Guidance for Admitted Patients
Please review the **AGP Job Aid** if patient is undergoing a AGP in a procedural area
	AGP	Precautions	Testing Indicated
Asymptomatic (Screening)	No	Standard	No
Asymptomatic (Screening)	Yes	Standard	No
Symptomatic (Diagnostic)	No	Contact/Droplet: Regardless of COVID test result If COVID negative, eligible for a semi-private room	Yes
Symptomatic (Diagnostic)	Yes	Expanded: Single negative pressure room, door closed If COVID negative, contact/droplet	Yes

**Room Assignment** Guidance for **COVID Positive Children**
	Not Receiving AGP	Receiving AGP
Precautions	Contact/Droplet	Expanded Precautions
Room Assignment	Negative Pressure room not required Single room Caregiver Guidance	Negative Pressure Rooms required Single room, door must remain closed Caregiver Guidance

Guidance for Discontinuation of Precautions

If exposed, bedside caregivers may need to continue their quarantine after the patient is considered COVID-recovered
Refer to Management of COVID-19 Positive or Symptomatic Parents and Caregivers

Resources

Posted: March 2020
Revised: December 2023

Authors:
- C. Kerman, MD;
- D, Davis, MD;
- K, O’Callaghan, MD;
- K. Chiotos, MD;
- J. Lavelle, MD;
- L. Handy, MD;
- J. Sammons, MD

Editors: Clinical Pathways Team

Evidence

Educational Media

If you have questions about any of the clinical pathways or about the process of creating a clinical pathway please contact us.

©2024 by Children's Hospital of Philadelphia, all rights reserved.
Use of this site is subject to the Terms of Use.

The clinical pathways are based upon publicly available medical evidence and/or a consensus of medical practitioners at The Children’s Hospital of Philadelphia (“CHOP”) and are current at the time of publication. These clinical pathways are intended to be a guide for practitioners and may need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, and/or the availability of various resources at the health care institution where the patient is located.

Accordingly, these clinical pathways are not intended to constitute medical advice or treatment, or to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia (“CHOP”), its physicians and the individual patients in question. CHOP does not represent or warrant that the clinical pathways are in every respect accurate or complete, or that one or more of them apply to a particular patient or medical condition. CHOP is not responsible for any errors or omissions in the clinical pathways, or for any outcomes a patient might experience where a clinician consulted one or more such pathways in connection with providing care for that patient.

Inpatient Clinical Pathway for Screening/Evaluation of Children with Suspected 2019 Novel Coronavirus (COVID-19) Disease

Evidence

Educational Media